Clinical

British Journal of Cancer (2003) 89, 246–247. doi:10.1038/sj.bjc.6601116 www.bjcancer.com
Published online 15 July 2003

ZD 1839 in patients with brain metastases from non-small-cell lung cancer (NSCLC): report of four cases

F Cappuzzo1, C Calandri1, S Bartolini1 and L Crinò1

1Division of Medical Oncology, Bellaria Hospital, Via Altura 3, 40139 Bologna, Italy

Correspondence: Dr F Cappuzzo, E-Mail: federico.cappuzzo@ausl.bo.it

Received 25 February 2003; Accepted 21 April 2003.

Top

Abstract

The activity of ZD 1839 on brain metastases (BM) from Non-Small-Cell Lung Cancer (NSCLC) is unknown. We report four cases of BM responding to ZD 1839 theraphy.

Keywords:

tyrosine kinase inhibitor, ZD 1839, non-small-cell lung cancer